14.28
+0.13(+0.92%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
535
First IPO Date
July 06, 2011
| Name | Title | Pay | Year Born |
| Feng Zhao | General Manager | 0 | 1978 |
| Huaixin Hou | Deputy General Manager | 0 | 1968 |
| Weikun Zhang | Deputy General Manager | 0 | 1986 |
| Xianggui Lin | Deputy General Manager | 0 | 1983 |
| Zhen You | Deputy General Manager | 0 | 1981 |
| Ruofeng Yi | Chief Financial Officer & Accounting Supervisor | 0 | 1977 |
| Xu Qingrong | Deputy GM & Secretary | 0 | 1981 |
| Junhui Zhao | Executive Vice President | 0 | 1976 |
| Guofeng Xu | Chief Technology Officer | 0 | N/A |
Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.
